Literature DB >> 7040848

Hypolipidemia.

M J Malloy, J P Kane.   

Abstract

Clinically significant hypolipidemia, although less common than hyperlipidemia, usually has important consequences that involve derangement of one or more of the major roles of lipoproteins. Deficiencies of lipoproteins are discussed under their classification as genetic disorders or as the presenting features of underlying disease.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7040848     DOI： 10.1016/s0025-7125(16)31431-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  16 in total

Review 1.  Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia.

Authors:  R Lodi; R Rinaldi; A Gaddi; S Iotti; R D'Alessandro; N Scoz; M Battino; V Carelli; G Azzimondi; P Zaniol; B Barbiroli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

2.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes.

Authors:  J D Sparks; C E Sparks; L L Miller
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

5.  Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology.

Authors:  G M Berger; G Brown; H E Henderson; F Bonnici
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

6.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.

Authors:  T L Innerarity; S G Young; K S Poksay; R W Mahley; R S Smith; R W Milne; Y L Marcel; K H Weisgraber
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Segregation analysis of low levels of high-density lipoprotein cholesterol in the collaborative Lipid Research Clinics Program Family Study.

Authors:  K D Bucher; E B Kaplan; K K Namboodiri; C J Glueck; P Laskarzewski; B M Rifkind
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

8.  Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.

Authors:  S G Young; S J Bertics; L K Curtiss; B W Dubois; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

Authors:  S G Young; S J Bertics; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes.

Authors:  J D Sparks; C E Sparks; M Bolognino; A M Roncone; T K Jackson; J M Amatruda
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.